摘要
目的探讨超选择性肝动脉灌注化疗栓塞术(TACE)治疗中晚期性肝癌患者的效果。方法回顾性总结67例中晚期肝癌患者在综合治疗基础上行超选择TACE,随访12～48个月观察患者生存情况。结果多数患者症状改善,生活质量明显提高。患者介入治疗后肿瘤都有不同程度缩小,肿瘤完全缓解1例1.5%(1/67),部分缓解34例50.7%(34/67),稳定30例44.8%,进展2例2.9%,有效率52.2%(35/67)。随访65人12～36个月,存活1年生存率59.7%(40/67),2年生存率22.4%(15/67),3年生存率7.5%(5/67)。结论超选择性肝动脉灌注化疗栓塞术(TACE)治疗中晚期肝癌,能有效地延长病人的生存期,提高病人生活质量,是中晚期肝癌非手术疗法的首选方法。
Objective To observe the efficiency of the treatment of transcatheter arterial chemoembolization（TACE） for advanced unresectable hepatocellular carcinoma. Methods 67 cases of advanced unresectable hepatocellular carcinoma receiving interventional therapy were studied retrospectively, and followed up one-three years. Results Most patients＇ symptom and life quality improved after the treatment with TACE. 1 cases showed complete remission （CR） 1 cases, partial remission34 cases, no remission 30 cases and progressive disease 2 cases, the response rate was 52.2% .65 patients were followed-up, the overalll-,2-and3-year survival rate was59.7%,22.4%,7.5%. Conclusion The TACE is a primary mothad for advanced unresectable hepatocellular carcinoma.
出处
《当代医学》
2010年第31期71-72,共2页
Contemporary Medicine
关键词
中晚期肝癌
TACE
advanced unresectable hepatocellular carcinoma
TACE
